Tuberculosis in HIV-positive children often missed from incidence data: the influence of HAART on paediatric TB
12 May 2006. Related: Conference reports, Paediatric care, TB coinfection.
Conference reports
Nevirapine pharmacokinetics with infant prophylaxis
12 May 2006. Related: Conference reports, Paediatric care.
Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy
12 May 2006. Related: Conference reports, HIV prevention and transmission.
K65R frequently emerges within 1-6 weeks of tenofovir monotherapy in macaques
12 May 2006. Related: Conference reports, HIV prevention and transmission.
A genome armed against HIV
12 May 2006. Related: Conference reports, HIV prevention and transmission.
Circumcision: a surprising benefit from an unkind cut
12 May 2006. Related: Conference reports, HIV prevention and transmission.
Topical microbicides: the real front line of HIV prevention
12 May 2006. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy
3 May 2006. Related: Conference reports.
Further reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
13 April 2006. Related: Conference reports.
Pharmacokinetics of antiretrovirals in pregnancy: tenofovir, nelfinavir, lopinavir/r
13 April 2006. Related: Conference reports, Pregnancy.
Risk of central nervous system birth defects associated with ART exposure during pregnancy
13 April 2006. Related: Conference reports, Pregnancy.
No increase in adverse pregnancy outcomes in Thai women receiving nevirapine-containing HAART
13 April 2006. Related: Conference reports, Pregnancy.
ARV treatment following singe dose nevirapine exposure
13 April 2006. Related: Conference reports, Women's health.
Association of HIV replication capacity with mother to child transmission
13 April 2006. Related: Conference reports, Pregnancy.
Association between HIV subtype and detection of K103N
13 April 2006. Related: Conference reports, Pregnancy, Drug resistance.
Pharmacology and drug interaction studies in adults: summary table from CROI, ICAAC and EACS conferences
12 April 2006. Related: Conference reports, PK and drug interactions.
Other new antiretrovirals at Denver: the future seems bright
12 April 2006. Related: Conference reports, Antiretrovirals.
Origins of HIV traced to chimpanzees in Cameroon
12 April 2006. Related: Conference reports.
HSV-2 suppression reduces HIV and HSV shedding
12 April 2006. Related: Conference reports, HIV prevention and transmission.
13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
26 March 2006. Related: Conference reports.
Early integrase inhibitor studies in treatment experienced patients raise hopes for new drugs in a new class
25 March 2006. Related: Conference reports, Antiretrovirals.
Atazanavir in treatment naive patients, with and without ritonavir boosting
25 March 2006. Related: Conference reports, Antiretrovirals.
Simplification to atazanavir/ritonavir monotherapy
25 March 2006. Related: Conference reports, Treatment strategies.
Summary of STI studies: SMART shows clear increased risk from interrupting treatment at any CD4 count
25 March 2006. Related: Conference reports, Treatment strategies, Coinfections and complications.
The effect of repeated single-dose nevirapine for PMTCT in a second pregnancy
25 March 2006. Related: Conference reports, Pregnancy.
Should criteria for initiation of HAART be revisited in pregnant women?
25 March 2006. Related: Conference reports, Pregnancy.
Cotrimoxazole prophylaxis in pregnancy
25 March 2006. Related: Conference reports, Pregnancy.
Treatment in primary HIV infection
25 March 2006. Related: Conference reports, Treatment strategies.
CNS penetration of ARV drugs is associated with lower CSF viral load
25 March 2006. Related: Conference reports, Antiretrovirals.
Sexual transmission of hepatitis C in HIV-positive men in the UK
25 March 2006. Related: Conference reports, Hepatitis coinfection.
D:A:D study shows that PIs rather than NNRTIs drive the previously reported cardiovascular risk of combination antiretroviral therapy
25 March 2006. Related: Conference reports, Side effects.
Interventions for the management of lipodystrophy and metabolic complications
25 March 2006. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA
16 March 2006. Related: Conference reports.
One third of HIV/HCV coinfected patients with normal ALT have advanced fibrosis in Spanish cohort
16 March 2006. Related: Conference reports, Hepatitis coinfection.
10th European AIDS Conference (EACS), 17-20 November 2005, Dublin, Ireland
11 February 2006. Related: Conference reports.
Rifaximin cure reported for cryptosporidium in advanced HIV
11 February 2006. Related: Conference reports, Coinfections and complications.
Analysis of hepatic events in 2NN study by CD4 entry criteria, levels differences between nevirapine and efavirenz; excess hepatic events in once-daily nevirapine arm linked to single site in Thailand
11 February 2006. Related: Conference reports, Side effects.
FTC studies at EACS: reduced incidence of M184V compared to 3TC; side effect profile in clinical practice
11 February 2006. Related: Conference reports, Antiretrovirals.
Paediatric studies at EACS: trends in antiretroviral use in the Madrid Cohort; life expectancy significantly increased HIV/HCV co-infected children since HAART; use of tenofovir in treatment experienced children; switching to lopinavir/r from double protease inhibitor regimen; once daily lopinavir/r, 3TC and abacavir; planned treatment interruptions in children
11 February 2006. Related: Conference reports, Paediatric care.
Efficacy of lopinavir/r in patients with advanced HIV (CD4 <25 cells/mm3)
11 February 2006. Related: Conference reports, Antiretrovirals.
Potential barriers to use of T-20: results from patient and physician interviews
11 February 2006. Related: Conference reports, Antiretrovirals.
Factors associated with sexual dysfunction in HIV patients
11 February 2006. Related: Conference reports, Side effects.
Decreased varicella zoster immunity in migrants from sub-Saharan Africa
11 February 2006. Related: Conference reports, Coinfections and complications.
Clinical experience of switching to atazanavir in the UKs largest clinic
11 February 2006. Related: Conference reports, Antiretrovirals.
Replacing a PI with atazanavir: separating swans from ducklings?
11 February 2006. Related: Conference reports, Antiretrovirals.
TMC 125: some good and bad news
11 February 2006. Related: Conference reports, Antiretrovirals.
When to change a failing regimen: second-line and salvage strategies
11 February 2006. Related: Conference reports, Antiretrovirals.
Antiretrovirals and other stuff!
11 February 2006. Related: Conference reports, Antiretrovirals.
Heart disease in people with HIV
11 February 2006. Related: Conference reports.
Mortality trends: why people with HIV die (or dont) today
11 February 2006. Related: Conference reports.
45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA
10 February 2006. Related: Conference reports.
Understanding TMC114 power against resistant HIV
10 February 2006. Related: Conference reports, Antiretrovirals.
New antiretroviral compounds at ICAAC: new PI brecanavir from GSK; maturation inhibitor PA-457; antiviral activity of monoclonal antibody; TNX-355 in treatment experienced patients
10 February 2006. Related: Conference reports, Antiretrovirals.
Comparison of pharmacokinetics of originator and generic liquid formulations and split tablets in Malawian children
10 February 2006. Related: Conference reports, Paediatric care.
African-Americans in ACTG 5095 had shorter time to virologic failure and grade 3/4 side effects
10 February 2006. Related: Conference reports, Side effects.
Predictors of insulin resistance in first year of therapy
10 February 2006. Related: Conference reports, Side effects.
Three measures confirm 144-week renal record of tenofovir
10 February 2006. Related: Conference reports, Antiretrovirals.
Low rash risk with efavirenz after nevirapine rash
10 February 2006. Related: Conference reports, Antiretrovirals.
7th Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 13-16 November 2005, Dublin, Ireland
13 December 2005. Related: Conference reports.
Monitoring side effects in resource limited countries
13 December 2005. Related: Conference reports, Side effects.
Uridine supplement reverses thymidine-induced lipoatrophy
13 December 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Pravastatin increases limb fat in HIV-positive patients with hypercholesterolaemia
13 December 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Evidence that facial fat can return after switching from either d4T or AZT, to abacavir or tenofovir
13 December 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Niacin has beneficial effect on lipids but no reduction in abdominal fat
13 December 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Gluteal implants used to replace lost buttock fat
13 December 2005. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.